Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

JSPR

JSPR News

Newswire

11:55

Jasper Therapeutics shares rise 10.91% intraday on positive ETESIAN study data and investor webinar announcement.

04:03

Jasper Therapeutics shares surge 24.41% premarket on positive ETESIAN study data for Briquilimab in asthma and BEACON study investigation resolution.

17:57

Jasper Therapeutics Discusses BEACON Study Anomalies and Preliminary ETESIAN Asthma Data

16:01

Jasper Therapeutics shares surge 22.11% after-hours after reporting positive ETESIAN study data and resolving BEACON study issues.

12:24

Briquilimab Shows Positive Results in ETESIAN Phase 1b Study, Asthma Treatment Advances

View More

About JSPR

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More